本页面由Tiger Trade Technology Pte. Ltd.提供服务

Wave Life Sciences Pte. Ltd

3.14
-0.1400-4.27%
盘后:3.150.0100+0.32%17:34 EDT
成交量:418.24万
成交额:1,315.72万
市值:6.19亿
市盈率:-2.92
高:3.27
开:3.27
低:3.07
收:3.28
52周最高:21.73
52周最低:3.07
股本:1.97亿
流通股本:9,476.50万
量比:1.60
换手率:4.41%
股息:- -
股息率:- -
每股收益(TTM):-1.0766
每股收益(LYR):-1.2118
净资产收益率:-67.42%
总资产收益率:-33.60%
市净率:1.36
市盈率(LYR):-2.59

数据加载中...

2022/08/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/08/11

重要事件披露

8-K - Current report
2022/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/07/20

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/21

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2022/06/14

重要事件披露

8-K - Current report
2022/05/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/05/12

重要事件披露

8-K - Current report
2022/05/12

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/02

SEC问询函

CORRESP [Cover] - Correspondence
2022/04/28

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/04/04

重要事件披露

8-K - Current report
2022/03/03

重要事件披露

8-K - Current report
2022/03/03

重要事件披露

8-K - Current report
2022/03/03

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals